JPMORGAN CHASE & CO Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments
JPMORGAN CHASE & CO (VYLD) reported Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments of $81.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2015-02-24
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2014-12-31 was $31.00M, a 210.00% increase year-over-year.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2014-09-30 was $8.00M, a 82.22% decline year-over-year.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2014-06-30 was $12.00M, a 90.77% decline year-over-year.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2014-03-31 was $33.00M, a 93.52% decline year-over-year.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2014 was $81.00M, a 88.23% decline from fiscal 2013.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2013 was $688.00M, a 68.04% decline from fiscal 2012.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2012 was $2.15B, a 29.00% increase from fiscal 2011.
- JPMORGAN CHASE & CO available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2011 was $1.67B, a 45.55% decline from fiscal 2010.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 3 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 6 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 9 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 12 month |
|---|---|---|---|---|
| 2014-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $39.00M derived: sum of 2 quarters · filed 2015-02-24 | $51.00M derived: sum of 3 quarters · filed 2015-02-24 | $81.00M 10-K · filed 2015-02-24 |
| 2014-09-30 | $8.00M 10-Q · filed 2014-11-03 | $20.00M derived: sum of 2 quarters · filed 2014-11-03 | $50.00M 10-Q · filed 2014-11-03 | $63.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2014-06-30 | $12.00M 10-Q · filed 2014-08-04 | $44.00M 10-Q · filed 2014-08-04 | $55.00M derived: sum of 3 quarters · filed 2015-02-24 | $100.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2014-03-31 | $33.00M 10-Q · filed 2014-05-02 | $43.00M derived: sum of 2 quarters · filed 2015-02-24 | $88.00M derived: sum of 3 quarters · filed 2015-02-24 | $218.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $55.00M derived: sum of 2 quarters · filed 2015-02-24 | $185.00M derived: sum of 3 quarters · filed 2015-02-24 | $688.00M 10-K · filed 2015-02-24 |
| 2013-09-30 | $45.00M 10-Q · filed 2014-11-03 | $175.00M derived: sum of 2 quarters · filed 2014-11-03 | $678.00M 10-Q · filed 2014-11-03 | $787.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $130.00M 10-Q · filed 2014-08-04 | $639.00M 10-Q · filed 2014-08-04 | $742.00M derived: sum of 3 quarters · filed 2015-02-24 | $1.20B derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $509.00M 10-Q · filed 2014-05-02 | $612.00M derived: sum of 2 quarters · filed 2015-02-24 | $1.07B derived: sum of 3 quarters · filed 2015-02-24 | $2.14B derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $564.00M derived: sum of 2 quarters · filed 2015-02-24 | $1.63B derived: sum of 3 quarters · filed 2015-02-24 | $2.15B 10-K · filed 2015-02-24 |
| 2012-09-30 | $461.00M 10-Q · filed 2013-11-01 | $1.53B derived: sum of 2 quarters · filed 2013-11-01 | $2.05B 10-Q · filed 2013-11-01 | $2.14B derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | $1.07B 10-Q · filed 2013-08-07 | $1.61B 10-Q · filed 2013-08-07 | $1.68B derived: sum of 3 quarters · filed 2014-02-20 | $2.30B derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | $543.00M 10-Q · filed 2013-05-08 | $608.00M derived: sum of 2 quarters · filed 2014-02-20 | $1.23B derived: sum of 3 quarters · filed 2014-02-20 | $2.08B derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | $65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $687.00M derived: sum of 2 quarters · filed 2014-02-20 | $1.54B derived: sum of 3 quarters · filed 2014-02-20 | $1.67B 10-K · filed 2014-02-20 |
| 2011-09-30 | $622.00M 10-Q · filed 2012-11-08 | $1.47B derived: sum of 2 quarters · filed 2012-11-08 | $1.60B 10-Q · filed 2012-11-08 | $2.86B derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $850.00M 10-Q · filed 2012-08-09 | $982.00M 10-Q · filed 2012-08-09 | $2.23B derived: sum of 3 quarters · filed 2013-02-28 | $2.34B derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $132.00M 10-Q/A · filed 2012-08-09 | $1.39B derived: sum of 2 quarters · filed 2013-02-28 | $1.49B derived: sum of 3 quarters · filed 2013-02-28 | $2.49B derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.35B derived: sum of 2 quarters · filed 2013-02-28 | $2.35B derived: sum of 3 quarters · filed 2013-02-28 | $3.06B 10-K · filed 2013-02-28 |
| 2010-09-30 | $102.00M 10-Q · filed 2011-11-04 | $1.10B derived: sum of 2 quarters · filed 2011-11-04 | $1.81B 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $1.00B 8-K · filed 2011-11-04 | $1.71B 8-K · filed 2011-11-04 | ||
| 2009-12-31 | $1.69B 10-K · filed 2012-02-29 |